Truist Financial’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Truist Financial's ADPT Position: Q2 2026 in Review
Truist Financial increased its Adaptive Biotechnologies (ADPT) stake by 15% in Q2 2026, buying an estimated $24.7K and bringing the position to 12,611 shares worth $271K. The position accounts for ﹤0.01% of the portfolio, ranked #2599.
Truist Financial first reported a position in ADPT in Q1 2026 and has held it in 2 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Truist Financial held 12,611 shares of Adaptive Biotechnologies worth $271K as of Q2 2026.
- Truist Financial bought 1,613 Adaptive Biotechnologies shares in Q2 2026, an estimated $24.7K.
- Adaptive Biotechnologies made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2599 holding.
- Truist Financial first reported a position in Adaptive Biotechnologies in Q1 2026 and has held it in 2 quarters since.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.